Krystal Biotech Inc (KRYS) USD0.00001

Sell:$147.49Buy:$147.68$2.15 (1.43%)

NASDAQ:0.05%
Market closed | Prices delayed by at least 15 minutes
Sell:$147.49
Buy:$147.68
Change:$2.15 (1.43%)
Market closed | Prices delayed by at least 15 minutes
Sell:$147.49
Buy:$147.68
Change:$2.15 (1.43%)
Market closed | Prices delayed by at least 15 minutes

Company Information

About this company

Krystal Biotech, Inc. is an integrated, commercial-stage biotechnology company. The Company is focused on the discovery, development, and commercialization of genetic medicines to treat diseases with high unmet medical needs. Its product candidates in various stages of clinical and preclinical development include KB407, KB408, KB707, KB105, KB801, KB803, KB304 and KB301. Its commercial product, VYJUVEK, is a redosable gene therapy, and a genetic medicine approved in the United States and Europe for the treatment of dystrophic epidermolysis bullosa. KB407 is being developed for the treatment of Cystic Fibrosis. KB408 is being developed for the treatment of Alpha-1 Antitrypsin Deficiency, a rare lung disease. KB707 is being developed for the treatment of solid tumors. KB105 is being developed for TGM1-Deficient Autosomal Recessive Congenital Ichthyosis. KB803 is a redosable eye drop formulation of B-VEC, designed for the treatment of ocular complications.

Key people

Krish S. Krishnan
Chairman of the Board, President, Chief Executive Officer
Suma M. Krishnan
President - Research and Development, Founder, Director
Kathryn A. Romano
Chief Accounting Officer
Daniel S. Janney
Lead Independent Director
Julian S. Gangolli
Independent Director
Kirti Ganorkar
Independent Director
Christopher Mason
Independent Director
Catherine Mazzacco
Independent Director
Click to see more

Key facts

  • EPIC
    KRYS
  • Location
    United States
  • Sector
    Healthcare
  • Industry
    Biotechnology & Drugs
  • ISIN
    US5011471027
  • Market cap
    $4.34bn
  • Employees
    275
  • Shares in issue
    28.90m
  • Exchange
    NASDAQ
  • Index
    S&P 600 Small Cap, TR Equity United States Index

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.